drugset / Trial / NCT05551897
A Study to Assess the Pharmacokinetics of Camizestrant (AZD9833) When Administered Alone and in Combination With Itraconazole
NaSingle-groupOpen-labelOther
Summary
This study will be conducted in healthy post-menopausal female subjects to assess the pharmacokinetics (PK) of Camizestrant (AZD9833) when administered alone and in combination with Itraconazole.
Timeline
- Start
- 2022-10-04
- Primary completion
- 2022-12-28
- Completion
- 2022-12-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Camizestrant | Other / unclassified | — | Oral |
| Subject | Itraconazole | Small molecule | — | — |
Indications
No indication recorded.